Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin receptor antagonist attenuates diabetes-induced endothelial lesions

Aug. 24, 2004

Artesian researchers claim dual beta-AR/PDE3 inhibitors

Aug. 23, 2004

Multichannel blocker attenuates arrhythmia and cardiac failure

Aug. 23, 2004

Nippon Shinyaku presents novel potent non-prostanoid prostacyclin agonist

Aug. 19, 2004

Canadian approval for Tiazac XC

Aug. 19, 2004

Dual angiotensin/endothelin antagonists prepared and tested at Kyowa Hakko

Aug. 19, 2004

Phytoestrogen shows vasodilating effects in vitro

Aug. 19, 2004

Sesame oil shows beneficial effects in hypertensive patients

Aug. 19, 2004

European approval for higher dosage of candesartan cilexetil

Aug. 18, 2004

Medinox and PUMC to develop NOX-100 in China and South Korea

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...